Skip to main content

MoneyWorks4Me

Concord Biotech informs about annual report

01 Jul 2024 Evaluate

Pursuant to Regulation 34 of Listing Regulations, Concord Biotech has informed that it enclosed Annual Report of the Company for the Financial Year 2023-24.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1896.00
Dr. Reddys Labs. 1376.00
Cipla 1417.00
Lupin 2021.00
Zydus Lifesciences 1190.10
View more..